The latest research, 'US Migraine Market Highlights – 2014', provides the US migraine market analysis, competitive landscape, and migraine drug sales forecast in the US.
The research includes the US migraine market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track competitor drugs sales and market share in the US migraine market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US migraine market.
SCOPE OF THE REPORT
What are the drugs marketed in the US for treating migraine?
Identify drugs marketed in the US for treating migraine including trade name, molecule name, company, and year of launch.
How big is the US migraine market?
Find out estimates for the US migraine market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
What is my competitor’s drugs market share in the US migraine market?
You will know the market share of leading migraine brands in the US, including generics share.
What are the key molecules in pipeline for migraine?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of migraine. Our coverage includes molecule, mechanism of action, and the originator.
What is the future of the US migraine market?
Gain insights into how the US migraine market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
Future migraine drugs forecast in the US
Find out how migraine drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.